Order Entry
Belgium
ContactUsLinkComponent
 
Recombinant Human DNA topoisomerase I (from Insect cells (Sf9))
  USBIT8065-02
New Product
 :  
Recombinant Human DNA topoisomerase I (from Insect cells (Sf9))
  USBIT8065-02
New Product
 :  

 

  • Cdt:
    20 µG
  • Type d'enzyme:
    Recombinant
  • Source:
    Insect cells (Sf9)
  • Species:
    Human
  • Conditions de stockage:
    May be stored at 4 °C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at −20 °C. Aliquots are stable for 6 months after receipt at −20 °C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
  • Formulaire:
    Supplied as a liquid in 16 mM HEPES, pH 7,5, 400 mM sodium chloride, 20% glycerol
  • Conditions de transport:
    20
  • Nom de l'enzyme:
    DNA topoisomerase I
  • Purity:
    ≥95% (SDS-PAGE)
  • Molecular weight:
    91,58
  • Concentration:
    ~0,9 mg/ml
  • N°:
    Highly purified

 

 

DNA topoisomerase I is a key nuclear enzyme that interconverts supercoiled DNA to the required topological conformations for normal DNA replication and transcription.

This enzyme is the target antigen for the so-called Scl-70 autoantibodies. Scl-70 antibodies are a specific marker in Scleroderma patients (specificity 98 to 100%) and are associated with the presence of diffuse skin involvement and pulmonary fibrosis.

In human tissues the DNA topoisomerase I is initially synthesised as a protein with 100 kDa molecular weight. Most of this precursor is then proteolytically processed to a species with 70 kDa molecular weight from which the Scl-70 antigen has derived its name.

Recombinant Human Scl-70 produced in SF9 is a glycosylated, polypeptide chain having a molecular mass of 91576 Da. Recombinant Scl-70 is expressed with a 6× His tag and purified by proprietary chromatographic techniques.

 : This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.